Our healthcare and life sciences regulatory team regularly interfaces with state and local government agencies on a wide variety of legislative and regulatory matters affecting the life sciences. We strive to gain an understanding of our pharmaceutical and medical device clients’ business including their particular strengths and vulnerabilities to state regulation, and in the process are able to effectively manage local lobbying and regulatory initiatives on our clients’ behalf.
Many of our lawyers and policy specialists have worked in healthcare regulatory agencies and legislative committees on both the state and federal levels, and in the process have developed first-hand knowledge of the political intricacies of policymaking affecting the pharmaceutical industry. While some of our attorneys are registered as federal and state lobbyists, we regularly work alongside lobbyists and public affairs professionals in the development and implementation of state based regulatory and legislative initiatives on behalf of our pharmaceutical clients. Our strengths lie in a collaborative approach to the achievement of our clients’ legislative and regulatory aims.
Areas of Focus
Our deep experience in state government strategies for life sciences includes:
State regulation
Employer issues
Tax and other economic incentive proposals
Related Practices & Industries
As our expertise is wide-ranging, our attorneys specialize in this related area:
STATE REGULATION OF THE PHARMACEUTICAL AND MEDICAL DEVICE INDUSTRIES
Our attorneys have advised our pharmaceutical and medical device clients on the Massachusetts pharmaceutical marketing law, its regulations and guidance issued by the Department of Public Health. We have been involved in an initiative to align the state reporting regulations with the requirements of the Federal Sunshine Act.
We have also advised our clients on proposed amendments to the Massachusetts anti-kickback statute that now permit the use of co-pay assistance coupons.
EMPLOYER ISSUES
Foley Hoag has represented several pharmaceutical companies in negotiating and securing economic benefit packages related to in-state relocations and expansions.
We have represented our pharmaceutical clients in matters related to state tax regulation both in Massachusetts and in neighboring states. Our projects include analysis of and proposed amendments to tax legislation concerning combined reporting, investment tax credit and net operating loss extension provisions, among others.
Events
We use cookies to enhance user experience, improve functionality and performance, and for analysis of website traffic. By clicking “accept”, you agree to the use of cookies. For more information about our cookie policy and the information we collect, please review our Privacy Statement.
Foley Hoag
Email Disclaimer
Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK," you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you.
If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Foley Hoag.
